This company has been marked as potentially delisted and may not be actively trading. Achaogen (AKAO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock AKAO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Triangle execs armed with $70M seek next big idea in life sciencesNovember 19, 2024 | bizjournals.comHarry R Weller's Net WorthSeptember 13, 2024 | benzinga.comRavi Viswanathan's Net WorthFebruary 21, 2024 | benzinga.comCOP28: Climate mums make themselves heard in halls of powerDecember 28, 2023 | bbc.comAKAOQ Historical DataOctober 25, 2023 | investing.comSepterna Strengthens Leadership Team to Advance Novel Small Molecule GPCR Medicines - Yahoo FinanceJuly 28, 2022 | finance.yahoo.comAn N.J. medical expert warns of the rise of superbugs | Opinion - NJ.comJune 13, 2022 | nj.comFlare Therapeutics Appoints Adrian Jubb as Chief Medical Officer - StreetInsider.comApril 28, 2022 | streetinsider.comFlare Therapeutics Appoints Adrian Jubb as Chief Medical Officer - Yahoo FinanceApril 26, 2022 | finance.yahoo.comCipla Calls Achaogen Claims Over Lost Ch. 11 Sales 'Weak' - Law360April 13, 2022 | law360.comGreater access to antibiotics is essential for curbing drug resistance - Financial TimesApril 13, 2022 | ft.comLife sciences VC 5AM Ventures adds 2 new funds totaling $750M - San Francisco Business Times - The Business JournalsApril 4, 2022 | bizjournals.comShortage of new antibiotics stokes fears of a 'silent pandemic' - The TimesMarch 19, 2022 | thetimes.co.ukForever In Love And In Love With Forever: Introducing The World's First True Longevity Couple - ForbesFebruary 14, 2022 | forbes.comGlobal Urinary Tract Infection Therapeutics Market Size Will Touch USD 11652 Million Mark by 2027, at a 4.56% CAGR - GlobeNewswireFebruary 2, 2022 | globenewswire.comApplied Molecular Transport Announces Board Appointments - Yahoo FinanceJanuary 27, 2022 | finance.yahoo.comTo avoid the superbug pandemic, we must fix the business model for new antibiotics - FortuneNovember 25, 2021 | fortune.comGlobal Antibiotic Resistance Markets, 2019-2020 & 2021-2027 - Focus on Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies - ResearchAndMarkets.com - Business WireNovember 4, 2021 | businesswire.comThe Top In-House Hires Of September - Law360October 8, 2021 | law360.comGlobal $13.8 Billion Antimicrobial Resistance Market, 2027 | Opportunity Breakdown by Disease, Pathogen, Drug Class, End-user and Region - ResearchAndMarkets.com - Business WireSeptember 27, 2021 | businesswire.comGlobal Antibody Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021 - PRNewswireSeptember 16, 2021 | prnewswire.comContraFect: Non-Antibiotic Alternative That Could Disrupt The Antibiotic Market - Seeking AlphaSeptember 15, 2021 | seekingalpha.comCRISPR Biotech Co. Mammoth Hires Sangamo Atty As GC - Law360September 9, 2021 | law360.comBiotech Dice led by Kevin Judice rolls toward $100M IPO - San Francisco Business Times - San Francisco Business TimesAugust 26, 2021 | bizjournals.comCarbapenem-Resistant Enterobacteriaceae Infection Market Insight, Epidemiology and Market Forecast Report 2021-2030 - ResearchAndMarkets.com - Business WireAugust 9, 2021 | businesswire.com Get Achaogen News Delivered to You Automatically Sign up to receive the latest news and ratings for AKAO and its competitors with MarketBeat's FREE daily newsletter. Email Address AKAO Media Mentions By Week AKAO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKAO News Sentiment▼0.000.80▲Average Medical News Sentiment AKAO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKAO Articles This Week▼00▲AKAO Articles Average Week Get Achaogen News Delivered to You Automatically Sign up to receive the latest news and ratings for AKAO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Rani Therapeutics News CalciMedica News Grace Therapeutics News Generation Bio News ALX Oncology News Eagle Pharmaceuticals News Daré Bioscience News Tempest Therapeutics News OnKure Therapeutics News Annovis Bio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKAO) was last updated on 5/15/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achaogen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achaogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AKAO Stock Free AKAO Stock Alerts